TRLV // Trulieve Cannabis Corp. Subordinate Voting Shares
DES <GO> NYSE RQD COCKPIT → CIK 0001754195 ↗Trulieve Cannabis Corp. Subordinate Voting Shares (TRLV) exhibits 60.2% gross margins and 12.8% return on invested capital within Health Care (Medicinal Chemicals and Botanical Products), balanced against a 9.9x enterprise multiple and 4.8% implied options volatility.
Sustained 60.2% gross profitability converts into 12.1% operating margin and 12.8% ROIC, outpacing sector cost of capital.
ROIC: 12.8% // GM: 60.2%YoY revenue trajectory of -0.4% paired with 11.20% free cash flow yield supports self-funded R&D and capital return.
REV YOY: -0.4% // FCF YLD: 11.20%Altman Z-Score of 1.12 and Piotroski F-Score of 6/9 indicate low near-term refinancing stress.
ALTMAN Z: 1.12 // F-SCORE: 6/9Trading at 24.0x trailing P/E (— Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 24.0x // EV/EBITDA: 9.9xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $10.60 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medicinal Chemicals and Botanical Products require continuous execution to defend -9.9% net margins.
NET MARGIN: -9.9% // D/E: 0.45x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for TRLV & activate live FRED threshold breach alerts.